SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001629137-16-000050
Filing Date
2016-06-17
Accepted
2016-06-17 17:28:25
Documents
1
Period of Report
2016-06-16
Filing Date Changed
2016-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbt-form8xk2016agmresults.htm 8-K 46720
  Complete submission text file 0001629137-16-000050.txt   48033
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 161720957
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1